BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 467961)

  • 1. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
    Priego JG; Maroto ML; Piña M; Catalan RE
    Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in hyperlipidemic rats.
    Priego JG; Maroto ML; Piña M; Catalán RE
    Gen Pharmacol; 1979; 10(4):315-8. PubMed ID: 488666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] lipid metabolism. II. Effects on the incorporation of various isotopic precursors in rat liver].
    Priego JG; Maroto ML; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):28-30. PubMed ID: 697397
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of etofibrate, clofibrate and nicotinic acid on the cyclic AMP-protein kinase system in rats.
    Catalán RE; Aragones MD; Martinez AM; Armijo M; Priego JG
    Gen Pharmacol; 1979; 10(6):455-8. PubMed ID: 230120
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies with etofibrate in the rat. Part I: Effects on glycerol, free fatty acid and triacylglycerol metabolism.
    Herrera E; Lasunción MA; Castro M; Gómez-Coronado D; Martín A; Quack G
    Biochim Biophys Acta; 1988 Nov; 963(1):42-52. PubMed ID: 3179329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various hypolipidemic drugs on fatty acid composition of liver and serum lipids.
    Maier R; Muller K
    Adv Exp Med Biol; 1975; 63():349-57. PubMed ID: 1199873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents affecting lipid metabolism. XL. Effect of ethyl chlorophenoxyisobutyrate on liver lipids and serum lipoproteins in rats.
    Hill P; Dvornik D
    Can J Biochem; 1971 Aug; 49(8):903-10. PubMed ID: 5120254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of ethofibrate [2-(nicotinoyloxy)ethyl-p-chlorophenoxyisobutyrate] on lipid metabolism. I. Effect on blood lipids in normal and hyperlipemic rats].
    Maroto ML; Priego JG; Piña M; Catalán RE
    Arch Farmacol Toxicol; 1978 Apr; 4(1):25-7. PubMed ID: 697396
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of etofibrate on platelet function: in vitro studies in human plasma.
    Ortega MP; Sunkel C; Armijo M; Priego JG
    Thromb Res; 1980 Aug; 19(3):409-16. PubMed ID: 7001672
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol metabolism.
    Lancet; 1973 Mar; 1(7802):524-5. PubMed ID: 4119954
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats.
    Petit D; Bonnefis MT; Rey C; Infante R
    Atherosclerosis; 1988 Dec; 74(3):215-25. PubMed ID: 3240333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver.
    Laker ME; Mayes PA
    Biochem Pharmacol; 1979 Sep; 28(18):2813-27. PubMed ID: 497030
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of clofibrate on the handling of dietary and liver fat.
    Westerfeld WW; Elwood JC; Richert DA
    Biochem Pharmacol; 1972 Apr; 21(8):1117-25. PubMed ID: 5034197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
    Kaiser W; Zöllner N
    Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
    Filip M; Păduraru I; Hriscu A; Neacşu R; Dănilă G; Filip F
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):341-5. PubMed ID: 3685700
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
    Weithmann KU; Granzer E
    Artery; 1980; 8(5):475-81. PubMed ID: 7011266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of 4-(4'-chlorobenzyloxy) benzyl nicotinate (KCD-232) on lipid metabolism in rats and mice].
    Okada K; Mochizuki T; Shinohara Y; Takahashi S; Takagi K; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):331-43. PubMed ID: 6745812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The lipid-reducing efficiency of a clofibrate-inositolnicotinate combination in comparison with clofibrate. The wrong use of statistical methods--presented on an example from clinical research].
    Haase W; Kluthe R; Schäfer B
    Med Welt; 1975 Nov; 26(47):2157-9. PubMed ID: 1105056
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lowering lipids rapidly and permanently with etofibrate].
    von Bock und Polach U
    Med Klin; 1982 Jan; 77(3):35-8. PubMed ID: 7057729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.